# A Clinical Randomized Controlled Trial of the New Method of Selective Coronary Vein Bypass Graft (SCVBG)

> **NCT03334110** · NA · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Coronary Atherosclerotic Heart Disease

## Interventions

- **PROCEDURE:** A method of operation: LIMA-GSV-SCVBG
- **PROCEDURE:** BIMA-SCVBG

## Key facts

- **NCT ID:** NCT03334110
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-30
- **Primary completion:** 2017-12
- **Final completion:** 2018-09
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334110, "A Clinical Randomized Controlled Trial of the New Method of Selective Coronary Vein Bypass Graft (SCVBG)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03334110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*